Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07418775 · ClinicalTrials.gov registry record
Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma
A clinical trial, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 3,000
- Enrollment target
NCT07418775: Recruiting study, sponsored by University of California, San Francisco.
NCT07418775 is a clinical trial that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 3,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07418775 is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 3,000 participants
- Enrollment target
Study Summary
Meningiomas are the most common primary brain tumor, and some groups are diagnosed with higher-grade tumors and have clinically worse outcomes. This study investigates social determinants of health and individual risk factors that may be associated with meningioma.
Primary Outcome
The prevalence of SSDH factors such as race and ethnicity, birthplace, relationship status, sexual orientation/gender identity, education level, socio-economic status, access to care, reproductive/menstrual history, health factors and medication use, chemical and radiation exposure, smoking history, and perceived stress for participants with meningioma will be analyzed using multilevel logistic and linear models accounting for geographical clustering.
Interventions
- BEHAVIORAL Questionnaire
- OTHER Medical Record Review
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2026-01-16 |
| Est. Completion | 2032-01-01 |
What NCT07418775 shows while recruiting
NCT07418775 is an observational study that tracks outcomes without assigning an intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 2 interventions - of which Questionnaire is the first listed.
NCT07418775 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07418775 about?
NCT07418775 is a clinical study titled "Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma". Meningiomas are the most common primary brain tumor, and some groups are diagnosed with higher-grade tumors and have clinically worse outcomes. This study investigates social determinants of health and individual risk factors that may be associated with meningioma.
What is the current status of trial NCT07418775?
This trial is currently recruiting. The enrollment target is 3,000 participants. The study started on 2026-01-16. Estimated completion is 2032-01-01.
What interventions are being tested in trial NCT07418775?
The interventions under investigation include: Questionnaire (BEHAVIORAL), Medical Record Review (OTHER).
Who is sponsoring clinical trial NCT07418775?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI